期刊文献+

Krebs型锑钨酸盐Na_(10)[Sb_2W_(20)Co_2O_(70)(H_2O)_6]·34H_2O的合成、结构及抗肿瘤活性研究 被引量:2

Synthesis,structure and antitumor activities of the Krebs-type Tungstoantimonate Na_(10)[Sb_2W_(20)Co_2O_(70)(H_2O)_6]·34H_2O
原文传递
导出
摘要 常规水溶液法合成了含钴的锑钨酸盐Na10[Sb2W20Co2O70(H2O)6].34H2O(1).单晶X-射线衍射表明,化合物1含2个三缺位的[SbW9]半单元,2个半单元通过2个WO3簇和2个CoO2簇相连.2个WO3簇和2个CoO2簇形成了1个四金属夹心带,2个WO3簇位于夹心带的中间,2个CoO2簇位于夹心带的两边,该结构为典型的Krebs型结构.体外抗肿瘤活性实验结果表明,化合物1对2种人体肿瘤细胞系—卵巢癌细胞(SK-OV-3)和肝癌细胞(SMMC-7721)—有明显的抑制活性. The Krebs-type Tungstoantimonate Na10[Sb2W20Co2O70(H2O)6]·34H2O 1 has been obtained in an aqueous solution.Single-crystal X-ray analysis shows that compound 1 crystallizes in triclinic crystal system,space group p-1 with a=1.334(5) nm,b=1.334(5) nm,c=1.811(5) nm,α = 85.278(5) °,β=71.108(5) °,γ=63.823(5) °.Polyanion 1 contains two tri-lacunary moiety units which are joined by two WO3 and two CoO2 groups forming a sandwich belt of four metal atoms.Compound 1 exhibits a typical Krebs structure.The result of antitumor activities in vitro shows that the title compound 1 has presented significant inhibitory actions on two human tumor cell lines,ovarian cancer cell line(SK-OV-3) and liver cancer cell line(SMMC-7721).
出处 《分子科学学报》 CAS CSCD 北大核心 2013年第4期350-352,共3页 Journal of Molecular Science
基金 黑龙江省教育厅科学技术研究项目(12531728)
关键词 多金属氧酸盐 合成 结构 抗肿瘤活性 polyoxometalate cobalt synthesis structure antitumor activity
  • 相关文献

参考文献11

  • 1POPE M T. Heteropoly and Isopoly Oxometalates [M]. Springer: Berlin, 1983:56-59..7N-72.
  • 2YAMASE T, POPE M T. Polyoxometalate Chemistry for Nano-Composite Design [M]. Dordrecht: Kluwer, 2002:83-96.
  • 3LONG D L, TSUNASHIMA R, CRONIN L. [J]. Angew Chem Int Ed, 2010, 49:1736-1758.
  • 4JIN L H, FANG Y X, PENG H, et al. [J]. Chem Commun, 2012, 48:2101-2103.
  • 5ARAGHI M, MIRKHANI V, MOGHADM M, et al. [J]. Dalton Trans, 2012,41:3087-3094.
  • 6FEFFREY T R, HILL C L, DEBORAH A J. [J]. Chem Rev, 1998,98:327-358.
  • 7SHIGETA S, MORI S, KODAMA E, et al. [J]. Antiviral Research, 2003,58:265-271.
  • 8LI C J, LU J M, Tu F, et al. [J]. Inorg Chem Commun, 2011,14:1192-1195.
  • 9TAN R X, PANG X H, WANG H, et al. [J]. Inorg Chem Commun, 2012,25:70-73.
  • 10BOSING M, LOOSE I, POHLMANN H, et al. [J]. Chem Eur J, 1997,3:1232-1237.

同被引文献17

  • 1刘杰,王恩波,计亮年.多金属氧酸盐抗病毒药物研究[J].化学进展,2006,18(1):114-119. 被引量:13
  • 2王恩波 胡长文 许林.多酸化学导论[M].北京:化学工业出版社,1990.14-16.
  • 3ZHANG Z M, YA()S, LI YG el al. [J]. ChemCommun, 2013,49:2515 2517.
  • 4SHA J Q, PENGJ, 1.I Y G, et al. [J]. Inorg Chem Commun, 2008,11:907 910.
  • 5TIAN A X, YING J, PENG J, et al. [J]. Inorghem, 2009,48=100-110.
  • 6PAN(; H J, PENG j, ZHANG C J, et ai. [J]. Chem ommun, 2010,,{6:5097-5099.
  • 7WAN(} J P, ZHA()J W, NIU J Y. [J]. Journal of Molecular Slructure. 2004,697:191-198.
  • 8MA F J, LIU SX, SUN (; Y, et al. [J]. J Am Chem Soc, 2011, 133:4178-4181.
  • 9SONG J, LUOZ, DAVIDK B, el al.[J]. J Am Chem Soc, 2011,133:16839-168,16.
  • 10HENDERSON L J, FRONCZEKFR, CHERRYWR. [J]. J AmChemSoc, 1984,106:5876-5879.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部